First batch of Sputnik V vaccine produced in Vietnam

Illustrative photo (Source: Sputnikvaccine.com))

Hanoi (VNA) – VABIOTECH,
one of Vietnam’s leading pharmaceutical companies, and the Russian Direct
Investment Fund (RDIF) on July 21 announced the production of a test batch of
the Russian Sputnik V vaccine against the coronavirus in  Vietnam.

According to , the made-in-Vietnam Sputnik V vaccine will be used in
the national immunisation programme after the technology transfer is completed
and it goes through quality control by Gamaleya Center, the Russian research
institute that develops the Sputnik V vaccine.

To date, Sputnik V has been registered in 68 countries with a
total population of over 3.7 billion, which is nearly half of the global
population. The data obtained by regulators of a number of countries during the
vaccination of people in Mexico, Argentina, Serbia, Bahrain, Hungary, the UAE,
and others, demonstrates that Sputnik V is one of the safest and most effective
vaccines against the coronavirus.

In Vietnam, Sputnik V got the approval by the Ministry of Health on March 23,
2021.

is being packaged  at VABIOTECH. (Photo: VABIOTECH)

“RDIF and VABIOTECH are actively cooperating in the technology transfer process
to provide easier access to Sputnik V for the population of Vietnam,” said
Kirill Dmitriev, CEO of the .

“As the pandemic is far from over and new, more dangerous variants of
coronavirus are being detected in various regions of the world, the RDIF is
increasing capacities for production of Sputnik V to speed up the vaccination
with one of the best vaccines in the world,” he added.

President of VABIOTECH Do Tuan Dat said he hopes the cooperation between the
RDIF and his firm will help provide quality and affordable vaccines to
Vietnam and other Southeast Asian countries./.